These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30288997)

  • 1. Deep learning and virtual drug screening.
    Carpenter KA; Cohen DS; Jarrell JT; Huang X
    Future Med Chem; 2018 Nov; 10(21):2557-2567. PubMed ID: 30288997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
    Gupta R; Srivastava D; Sahu M; Tiwari S; Ambasta RK; Kumar P
    Mol Divers; 2021 Aug; 25(3):1315-1360. PubMed ID: 33844136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data Integration Using Advances in Machine Learning in Drug Discovery and Molecular Biology.
    Hudson IL
    Methods Mol Biol; 2021; 2190():167-184. PubMed ID: 32804365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The power of deep learning to ligand-based novel drug discovery.
    Baskin II
    Expert Opin Drug Discov; 2020 Jul; 15(7):755-764. PubMed ID: 32228116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep Learning in Virtual Screening: Recent Applications and Developments.
    Kimber TB; Chen Y; Volkamer A
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development.
    Sarkar C; Das B; Rawat VS; Wahlang JB; Nongpiur A; Tiewsoh I; Lyngdoh NM; Das D; Bidarolli M; Sony HT
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Systematic Review of Deep Learning Methodologies Used in the Drug Discovery Process with Emphasis on In Vivo Validation.
    Koutroumpa NM; Papavasileiou KD; Papadiamantis AG; Melagraki G; Afantitis A
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine Learning-based Virtual Screening and Its Applications to Alzheimer's Drug Discovery: A Review.
    Carpenter KA; Huang X
    Curr Pharm Des; 2018; 24(28):3347-3358. PubMed ID: 29879881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Progress of Deep Learning in Drug Discovery.
    Wang F; Diao X; Chang S; Xu L
    Curr Pharm Des; 2021; 27(17):2088-2096. PubMed ID: 33511933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery.
    Yang X; Wang Y; Byrne R; Schneider G; Yang S
    Chem Rev; 2019 Sep; 119(18):10520-10594. PubMed ID: 31294972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep Learning in Structure-Based Drug Design.
    Anighoro A
    Methods Mol Biol; 2022; 2390():261-271. PubMed ID: 34731473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine learning and AI-based approaches for bioactive ligand discovery and GPCR-ligand recognition.
    Raschka S; Kaufman B
    Methods; 2020 Aug; 180():89-110. PubMed ID: 32645448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep Learning in Drug Discovery.
    Gawehn E; Hiss JA; Schneider G
    Mol Inform; 2016 Jan; 35(1):3-14. PubMed ID: 27491648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based drug design with geometric deep learning.
    Isert C; Atz K; Schneider G
    Curr Opin Struct Biol; 2023 Apr; 79():102548. PubMed ID: 36842415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtual Screening Meets Deep Learning.
    Pérez-Sianes J; Pérez-Sánchez H; Díaz F
    Curr Comput Aided Drug Des; 2019; 15(1):6-28. PubMed ID: 30338743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving quantitative structure-activity relationship models using Artificial Neural Networks trained with dropout.
    Mendenhall J; Meiler J
    J Comput Aided Mol Des; 2016 Feb; 30(2):177-89. PubMed ID: 26830599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of drug-target binding affinity based on deep learning models.
    Zhang H; Liu X; Cheng W; Wang T; Chen Y
    Comput Biol Med; 2024 May; 174():108435. PubMed ID: 38608327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A New Hybrid Neural Network Deep Learning Method for Protein-Ligand Binding Affinity Prediction and De Novo Drug Design.
    Limbu S; Dakshanamurthy S
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Ligand-based Big Data Deep Neural Network Models for Virtual Screening of Large Compound Libraries.
    Xiao T; Qi X; Chen Y; Jiang Y
    Mol Inform; 2018 Nov; 37(11):e1800031. PubMed ID: 29882343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of neural networks for drug discovery and the inputs used.
    Xu Y; Yao H; Lin K
    Expert Opin Drug Discov; 2018 Dec; 13(12):1091-1102. PubMed ID: 30449189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.